表紙
市場調查報告書
商品編碼
1044126

囊性纖維化 (CF) 治療領域-社交媒體研究

SONAR Cystic Fibrosis (CF) Therapy Area Report

出版日期: | 出版商: Lumanity | 英文 51 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告從利益相關者和企業的角度概述了囊性纖維化 (CF) 的社交媒體情況。

涵蓋企業:

  • Vertex Pharmaceuticals
  • Gilead Sciences
  • AbbVie
  • Chiesi
  • Genentech
  • Viatris
  • Nestle Health Science
  • Laurent Pharma
  • TranslateBio
  • Sanofi
  • ReCode Therapeutics

列出的產品:

  • Trikafta/Kaftrio
  • Symkevi
  • Orkambi
  • Kalydeco
  • Quinsair
  • Cayston
  • Pulmozyme
  • Creon
  • Bronchitol
  • Zenpep

目錄

簡介

CF 中的社交媒體情況概述

  • 社交媒體對話架構
  • 媒體類型功能
  • 對話的主要促進者

病人的聲音

  • CF 患者和護理人員之間的在線對話概述
  • 患者和護理人員的主要在線細分市場
  • 現有治療的未滿足需求
  • 患者對話總結和機會

臨床對話

  • HCP 在線對話概述
  • 專業線上板塊
  • 會議參與
  • DOL 標識
  • 臨床對話總結和機會

衝突信息

  • 各大公司的社交媒體活動
  • 分析公司收購/擁有的在線活動
  • 製藥行業的對話總結和機遇
目錄

Our ‘Cystic Fibrosis (CF) therapy area report’ offers a comprehensive overview of the CF social media landscape, and provides insight into multiple stakeholder and company perspectives. Understand emergent signals and key trends amongst patients, caregivers, HCPs and digital opinion leaders, as well as the opportunities that exists for pharma to better engage with these groups.

The report, which is based on both machine and human-led analysis, uncovers the personas of online stakeholders, the key unmet needs, and opportunities for pharma to engage with the online customers. Insights from our report can help boost pharma companies' engagement strategies, identify potential opportunities and mitigate business risks.

Companies mentioned:

  • Vertex Pharmaceuticals
  • Gilead Sciences
  • AbbVie
  • Chiesi
  • Genentech
  • Viatris
  • Nestlé Health Science
  • Laurent Pharma
  • TranslateBio
  • Sanofi
  • ReCode Therapeutics

Products mentioned:

  • Trikafta/Kaftrio
  • Symkevi
  • Orkambi
  • Kalydeco
  • Quinsair
  • Cayston
  • Pulmozyme
  • Creon
  • Bronchitol
  • Zenpep

Table of Contents

Introduction

  • Executive Summary
  • Methodology
  • Background

CF Social Media Landscape Overview

  • Social Media Conversation Architecture
  • Media Type Characteristics
  • Key Drivers of Conversation

The Patient Voice

  • Overview of Patient and Caregiver Online Conversation in CF
  • Key Patient and Caregiver Online Segments
  • Existing Treatment Unmet Needs
  • Summary and Opportunities from the Patient Conversation

Clinical Conversations

  • Overview of HCP Online Conversation
  • Professional Online Segments
  • Conference Engagement
  • DOL Identification
  • Summary and Opportunities from the Clinical Conversation

Competitive Intelligence

  • Key Company Social Media Activity
  • Analysis of Company Earned vs Owned Online Activity
  • Summary and Opportunities from the Pharma Conversation